Market Overview

Eros International Plc Reports Third Quarter Fiscal Year 2017 Results

Share:





Eros International Plc (NYSE: EROS) ("Eros" or "the Company"), a leading
global company in the Indian film entertainment industry, today reported
its quarterly financial results for the three and nine months ended
December 31, 2016.

Financial Highlights

Three Months Ended December 31, 2016

  • Revenues decreased by 5.3% to $57.3 million, compared to $60.5 million
    in the prior year period.
  • Operating profit increased by 1,540.0% to $8.2 million, compared to
    $0.5 million in the prior year period.
  • Net income increased by 560% to $11.5 million profit, compared to
    $(2.5) million loss in the prior year period.
  • Adjusted EBITDA increased by 62.9% to $14.5 million, compared to $8.9
    million in the prior year period(1).
  • The strong increase in margins and profitability vis-à-vis the slight
    decline in revenues is due to the negative impact of demonetization on
    theatrical revenues in the third quarter partially offset by strong
    high-margin catalogue sales.

Nine Months Ended December 31, 2016

  • Revenues decreased by 4.3% to $200.3 million, compared to $209.3
    million in the prior year period.
  • Operating profit decreased by 32.1% to $20.9 million, compared to
    $30.8 million in the prior year period.
  • Net Debt increased by 22.3% to $ 157.9 million as compared to $129.1
    million as of March 31, 2016
  • Adjusted EBITDA decreased by 18.1% to $46.3 million, compared to $56.5
    million in the prior year period. (1)
  • Net Debt increased by 22.3% to $ 157.9 million as compared to $129.1
    million as of March 31, 2016
  • The overall decrease in revenues and profitability vis-à-vis the nine
    months ended December 2015 is due to the difference in slate mix with
    three out of the top four box office films of 2015 already released in
    the first nine months compared to the negative impact of
    demonetization on theatrical revenues in the current year, partially
    offset by strong high-margin catalogue sales.

1. A reconciliation of the non-GAAP financial measures discussed within
this release to our GAAP operating results are included at the end of
this release. See also "Non-GAAP Financial Measures."

Operational Highlights as of December 31, 2016

  • Eight films during the third quarter of FY 2017 (vs 15 films in Q3
    FY2016). Modest reduction in number of releases reflects a strategic
    decision to hold back some releases until negative impact of
    demonetization has subsided.
  • Major releases for Q3 FY 2017 included: Rock On 2 (Hindi),
    Kahaani 2 (Hindi), Chaar Sahibzaade 2 (Punjabi) and
    Double Feluda
    (Bengali),
  • In January 2017, Eros International, Plc, announced an
    industry-leading film production pipeline of more than 50 films across
    eight languages involving over 40 directors.
  • Eros' in-house production company, Trinity Pictures, has announced its
    first franchise film Sniff – I Spy, a superhero film directed
    by Amole Gupte scheduled for release of May 5, 2017.
  • In addition, our two Indo‐China productions are scheduled for release
    in FY2018 - Kabir Khan's travel drama, untitled panda film & Siddharth
    Anand's cross‐cultural romantic comedy, Love in Beijing
  • Trinity Writers Room has been established and already completed
    development on 15 other franchises and 80 film concepts
  • Eros Now has over 58 million registered users worldwide across WAP,
    App and Web.
  • Eros Now crossed 2 million paying subscribers2 in December
    2016, three months ahead of its full year target
  • Eros Now has integration deals around the world with over 20 different
    telecom operators and nine different OEMs and connected devices.
  • Apple has featured the Eros Now app in its "App Store Best of 2016"
  • Over the past four months Eros Now has digitally premiered more than
    15 films from the Eros International new release slate.
  • Eros Now has entered into a strategic partnership in India with
    several leading electronic payment platforms including Paytm,
    Mobikwik, SBI Buddy and Freecharge which enable Eros Now subscribers
    to make easy and hassle free payments using the e-wallet service. On
    an aggregate basis these platforms reach over 260 million e-wallets in
    India.
  • Eros Now's original content offering began with the release of 'Salute
    Siachen', India's first ever celebrity high endurance expedition to
    the Siachen Glacier. In addition, Eros Now originals such as Flesh by
    Siddharth Anand, Smoke and Side Hero will be launched in FY 2018.

2. Paying subscribers means any subscriber who has made a valid payment
to subscribe to a service that includes the Eros Now service either as
part of a bundle or on a standalone basis, either directly or indirectly
through a telecom operator or OEM in any given month be it through a
daily, weekly or monthly billing pack, as long as the validity of the
pack is for at least one month.

Management Comments:

Jyoti Deshpande, Eros' Managing Director and Group Chief Executive
Officer, said:

"I am very proud of the progress we have made over the past few months
on our journey to transform our Company into a leading global digital
distribution business supported by the power of our brand, premium
content and unparalleled distribution capabilities. The momentum we
highlighted in November continues to accelerate with the growing success
of Eros Now, our OTT platform which reached 58 million registered users
and crossed 2 million paying subscribers in December 2016.

As we discussed in our Q2 results last November, the rapidly evolving
digital media landscape in India including increased competition from
Western OTT players for digital rights has underscored the value of
digital content in India. It also reinforces our overall strategy to
focus on premium content with the widest possible appeal. In the long
term the rising value of digital rights will make our existing content
library more valuable and increase the demand for our new release
digital content across all platforms – including satellite and Cable.

The demonetization efforts undertaken by the Indian Government in
November have clearly had a short-term impact on many aspects of the
Indian economy, especially consumer discretionary spending. To that end
while the entire media sector in India has been temporarily impacted by
these measures, we feel that the underlying push to digitization will
directly and indirectly benefit our Company going forward in many ways.
We have been working tirelessly to provide consumers with multiple
payment options for Eros Now, from telco billing to digital wallets to
mobile payment providers. The push to digitization reinforces our
strategy and we feel we are well positioned to capitalize on this
opportunity.

Finally, our strong upcoming production slate of over 50 films has gone
through a stringent green-lighting process for several months. The
upcoming lineup includes highly promising projects including five films
from Trinity, two Indo‐China co‐productions, a Shahrukh Khan film from
Color Yellow, two sequels from our own content stable like Vicky
Donor-2, Badlapur-2, Munna Michael starring Tiger Shroff and Chanda Mama
Door Ke starring Sushant Singh, amongst others."

Prem Parameswaran, Group Chief Financial Officer and President of North
America also commented:

"Our strong performance in the third quarter was driven primarily by
pre-sales across all revenue streams and increased catalogue sales
momentum – despite a modest impact from demonetization on our theatrical
revenues Although certain films released during the third quarter
delivered modest box office performances due to lack of theatre traffic,
we firmly believe that demonetization is a big opportunity for us in the
long term. Against this backdrop, we took the opportunity to push out
some of our new theatrical releases into the fourth quarter and beyond,
avoiding releases in an uncertain environment and instead focusing on
our catalogue monetization. As we look ahead, we are investing smartly
for the longer term in‐line with our portfolio approach across varied
budgets and languages."

Eros International Plc Financial Highlights:

   
Three Months Ended
December 31,
Nine Months Ended
December 31,
(dollars in millions) 2016   2015   % change   2016   2015   % change
Revenue $ 57,348   $ 60,452 5.3   $

200,319

  $

209,286

 

4.3

 
Gross Profit 22,319 17,541 27.4 68,345 79,844 14.4
 
Operating profit 8,200 478 1540.0 20,875 30,760 32.1
 
Net income 11,484 (2,453 ) 560 13,528 12,329 9.8
           
Adjusted EBITDA(1)

14,497

8,889 62.9 46,311 56,477 18.1
 

(1) A reconciliation of the non-GAAP financial measures discussed
within this release to our IFRS net income is included at the end
of this release. See also "Non-GAAP Financial Measures".

 

Financial Results for Three months and Nine Months Ended December 31,
2016

Revenue

For the three months ended December 31, 2016, Eros film slate comprised
8 films of which none were high budget, three were medium budget and
five were low budget as compared to 15 films in the three months ended
December 31, 2015, of which one was high budget, four were medium budget
and 10 were low budget. In the nine months ended December 31, 2016, Eros
film slate comprised 40 films of which five were high budget, nine were
medium budget and 26 were low budget as compared 51 films in the nine
months ended December 31, 2015, of which six were high budget, ten were
medium budget and 35 were low budget.

For the three months ended December 31, 2016, the Company's slate of 8
films comprised 2 Hindi films, 3 Tamil/Telugu films and 3 regional films
as compared to the same period last year where its slate of 15 films
comprised 7 Hindi films, 5 Tamil/Telugu films and 3 regional film. In
the nine months ended December 31, 2016, the Company's slate of 40 films
comprised 12 Hindi films, 16 Tamil/Telugu films and 12 regional films as
compared to the same period last year where its slate of 51 films
comprised 30 Hindi films, 16 Tamil/Telugu films and 5 regional films.

For the three months ended December 31, 2016, revenue decreased by 5.3%
to $ 57.3 million, compared to $60.5 million for the three months ended
December 31, 2015. In the nine months ended December 31, 2016, revenue
decreased by 4.3% to $200.3 million, compared to $209.3 million for the
nine months ended December 31, 2015.

For the three months ended December 31, 2016, aggregate theatrical
revenues decreased by 22.9% to $19.9 million from $25.8 million for the
three months ended December 31, 2015, mainly due to no high budget films
in the three months ended December 31, 2016 while the comparable period
had Bajirao Mastani, the third highest grossing film of 2015, as well as
the adverse impact of Rupee demonetisation by the Indian government in
November 2016 resulting in decreased footfalls in cinemas in India. In
the nine months ended December 31, 2016, the aggregate theatrical
revenues decreased by 26.5% to $88.6 million from $120.6 million for the
nine months ended December 31, 2015. The decrease in theatrical revenues
reflects the mix of films released in each period as reflected in the
table below. Theatrical revenues in the nine months ended December 31,
2015 comprised revenues from Bajrangi Bhaijaan, Bajirao Mastani, Tanu
Weds Manu Returns three out of the top four highest grossing films of
2015 in comparison to a less blockbuster slate in 2016 with Housefull 3
as the only top 10 film so far coupled with the negative impact of
demonetisation on the Indian film industry since November 2016.

For the three months ended December 31, 2016, aggregate revenues from
television syndication increased by 61.6% to $20.2 million from $12.5
million for the three months ended December 31, 2016, mainly due to a
significant contribution from catalogue sales while in the comparable
quarter in 2015, the company had decided to hold back catalogue sales to
bring about working capital efficiencies. In the nine months ended
December 31, 2016, the aggregate revenues from television syndication
increased by 44.3% to $65.8 million from $45.6 million for the nine
months ended December 31, 2015. This was due to resuming catalogue sales
since April 2017 after a brief hold back in catalogue sales in the last
two quarters of FY 2016 as reported and gaining significant momentum to
the sales in the three months ended December 31, 2016.

For the three months ended December 31, 2016, the aggregate revenues
from digital and ancillary decreased by 22.5% to $17.2 million from
$22.2 million for the three months ended December 31, 2015 again
reflecting the film slate mix in the comparable periods. In the nine
months ended December 31, 2016, the aggregate revenues from digital and
ancillary increased by 6.5% to $45.9 million from $43.1 million for the
nine months ended December 31, 2015 mainly driven by catalogue
monetization strategy, revenues from Eros Now and contribution from
other ancillary revenues streams.

               
Three months ended High Medium Low Total
December 31, 2016 - 3 5 8
December 31, 2015 1 4 10 15
 

Nine months ended

    High     Medium     Low     Total
December 31, 2016 5 9 26 40
December 31, 2015 6 10 35 51
 

Revenue from India decreased by 42.4% to $19.6 million in the three
months ended December 31, 2016, compared to $34 million in the three
months ended December 31, 2015 mainly due to the negative impact of the
rupee demonetisation on cinema footfalls. In the nine months ended
December 31, 2016, revenue from India decreased by 20.5% to $102.2
million, compared to $128.5 million in the nine months ended December
31, 2015. The decrease was mainly due to lower theatrical revenues from
a combination of rupee demonetisation impact as well as a weaker slate
mix with 2015 slate comprising of blockbuster hits such as Bajrangi
Bhaijaan, Bajirao Mastani and Tanu Weds Manu but partially offset by a
stronger catalogue revenue contribution.

Revenue from Europe decreased by 6.3% to $5.9 million in the three
months ended December 31, 2016, compared to $6.3 million in the three
months ended December 31, 2015. In the nine months ended December 31,
2016, revenue from Europe decreased by 34.1% to $15.1 million, compared
to $22.9 million in the nine months ended December 31, 2015. This was on
account of lower theatrical revenues of the comparable film slate but
partially offset by some catalogue sales in the current quarter.

Revenue from North America decreased by 85.4% to $0.6 million in the
three months ended December 31, 2016, compared to $4.1 million in the
three months ended December 31, 2015. In the nine months ended December
31, 2016, revenue from North America decreased by 82.1% to $2.5 million,
compared to $14 million in the nine months ended December 2015. This was
on account of relatively lower theatrical revenues from the film slate
and lower catalogue revenues.

Revenue from rest of the world increased by 94.4% to $31.3 million in
the three months ended December 31, 2016, compared to $16.1 million in
the three months ended December 31, 2015. In the nine months ended
December 31, 2016, revenue from the rest of the world increased by 83.6%
to $80.6 million, compared to $43.9 million in the nine months ended
December 31, 2015, mainly due to decreased theatrical revenues from the
film mix offset by increased catalogue revenues.

Cost of sales

For the three months ended December 31, 2016, cost of sales decreased by
18.4% to $35 million compared to $42.9 million in the three months ended
December 31, 2015. The decrease was mainly because of lower amortisation
costs associated with the comparable film mix and lower marketing and
advertising costs. But in nine months ended December 31, 2016, cost of
sales increased by 2.0% to $132 million compared to $129.4 million in
nine month period ended December 31, 2015, primarily due to increases in
cumulative amortization costs of $8 million in nine months ended
December 2016.

Gross profit

For the three months ended December 31, 2016, gross profit increased by
27.4% to $22.3 million, compared to $17.5 million in the three months
ended December 31, 2015. As a percentage of revenues, the company's
gross profit margin was 38.9% in the three months ended December 31,
2016, compared to 29.0% in the three months ended December 31, 2015.
This was mainly due to high margin catalogue revenues.

In the nine months ended December 31, 2016 gross profit decreased by
14.4% to $68.3million, compared to $79.8 million in the nine months
ended December 31, 2015. As a percentage of revenues, our gross profit
margin was 34.1% in the nine months ended December 31, 2016, compared to
38.2% in the nine months ended December 31, 2015. This was mainly due to
an overall weaker slate mix, reduced theatrical revenues for the films
released during the rupee demonetization in India but partially offset
by strong catalogue revenues.

Adjusted EBITDA

For the three months ended December 31, 2016, adjusted EBITDA increased
by 62.9% to $14.5 million compared to $8.9 million in the three months
ended December 31, 2015 mainly due to stronger catalogue sales in the
current period vis-à-vis holding back catalogue sales in the comparable
period. In the nine months ended December 31, 2016, adjusted EBITDA
decreased by 18.1% to $46.3 million, compared to $56.5 million in the
nine months ended December 31, 2015 mainly due to lower profitability of
the slate due to demonetization of the Indian rupee.

Administrative costs

For the three months ended December 31, 2016, administrative costs
decreased by 17.5% to $14.1 million compared to $17.1 million for the
three months ended December 31, 2015 mainly due to lower share based
compensation in this period. In the nine months ended December 31, 2016,
administrative costs decreased by 3.3% to $47.5 million compared to
$49.1 million for the nine months ended December 31, 2015, due to lower
share based compensation.

Net finance costs

For the three months ended December 31, 2016, net finance costs
increased by 54.5% to $3.4 million, compared to $2.2 million in the
three months ended December 31, 2015.In the nine months ended December
31, 2016, net finance costs increased by 59.4% to $11 million, compared
to $6.9 million in the nine months ended December 31, 2015, mainly due
to lower income from financing activities and increased borrowing at
India level

Income tax expense.

The provisions for income taxes were $3.6 million and $3.5 million for
the three months ended December 31, 2016 and 2015, respectively and in
the nine months ended December 31, 2016, the provisions for income taxes
were $10.2 million, compared to $13.3 million in the nine months ended
December 31, 2015, respectively. The decrease was on account of
relatively lower profit. Effective income tax rates were 21.1% and 25.9%
for the nine months ended December 31, 2016 and 2015, respectively
excluding non-deductible share-based payment charges. The change in
effective rate principally reflects a change in the pattern of the
profits subject to income tax amongst our subsidiaries.

Net Debt

As of December 31, 2016, net debt increased to $157.9 million from
$129.1 million as of March 31, 2016 mainly due to lower cash flow from
operating activities.

Conference Call

The Company will host a conference call on Tuesday, February 21, 2017,
at 8:30 AM Eastern Standard Time.

To access the call please dial (646) 254-3376 or (877) 280-3459 from the
United States, or +44(0)20 3427 1933 or +44(0)80 0279 4842 from outside
the U.S. The conference call I.D. number is 4764893. Participants should
dial in 5 to 10 minutes before the scheduled time.

A replay of the call can be accessed through February 28, 2017 by
dialing (347) 366-9565 or (866) 932-5017 from the U.S., or +44(0)20 3427
0598 or +44(0)80 0358 7735 from outside the U.S. The conference call
I.D. number is 4764893. The call will be available as a live webcast,
which can be accessed at Eros'
Investor Relations website
. A replay of the webcast recording will
be available until February 21, 2018.

Non-GAAP Financial Measures

Net Income

The Company uses the term Net Income, as the International Financial
Reporting Standards ("IFRS") define the term as synonymous with profit
for the period.

Adjusted EBITDA

In addition to the results prepared in accordance with IFRS provided in
this release, the Company has presented Adjusted Earnings Before
Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"). The
company uses Adjusted EBITDA along with other IFRS measures to evaluate
operating performance. Adjusted EBITDA is defined by the Company as net
income before interest expense, income tax expense and depreciation and
amortization (excluding amortization of capitalized film content and
debt issuance costs), adjusted for impairments of available-for-sale
financial assets, profit/loss on held for trading liabilities (including
profit/loss on derivatives) share based payments and transaction costs
relating to equity transactions.

Adjusted EBITDA, as used and defined by us, may not be comparable to
similarly-titled measures employed by other companies and is not a
measure of performance calculated in accordance with GAAP. Adjusted
EBITDA should not be considered in isolation or as a substitute for
operating income, net income, cash flows from operating investing and
financing activities, or other income or cash flow statement data
prepared in accordance with GAAP. Adjusted EBITDA provides no
information regarding a company's capital structure, borrowings,
interest costs, capital expenditures and working capital movement or tax
position. However, our management team believes that Adjusted EBITDA is
useful to investors in evaluating our results of operations because
these measures:

• are widely used by investors to measure a company's operating
performance without regard to items excluded from the calculation of
such term, which can vary substantially from company to company
depending upon accounting methods and book value of assets, capital
structure and the method by which assets were acquired, among other
factors;

• help investors to evaluate and compare the results of our operations
from period to period by removing the effect of our capital structure
from our operating structure; and

• are used by our management team for various other purposes, including
presentations to our board of directors as a basis for strategic
planning and forecasting.

See the supplemental financial schedules for a reconciliation of
Adjusted EBITDA to Net Income.

Cautionary Statement Concerning Forward-Looking Statements

Some of the information presented in this press release and in related
comments by Eros' management contains forward-looking statements. In
some cases, these forward-looking statements are identified by terms and
phrases such as "aim," ‘‘anticipate,''
‘‘believe,'' "feel," "contemplate," ‘‘intend,'' ‘‘estimate,'' ‘‘expect,'' ‘‘continue,'' ‘‘should,'' ‘‘could,'' ‘‘may,'' ‘‘plan,'' ‘‘project,'' ‘‘predict,''
‘‘will,'' "future," "goal," "objective," and similar expressions and
include references to assumptions and relate to Eros' future prospects,
developments and business strategies. Similarly, statements that
describe Eros' strategies, objectives, plans or goals are
forward-looking statements and are based on information available to
Eros as of the date of this press release. Forward-looking statements
are subject to risks, uncertainties and assumptions that could cause
actual results to differ materially from those contemplated by the
relevant statement. Such risks and uncertainties include a variety of
factors, some of which are beyond Eros' control, including but not
limited to market conditions and economic conditions. Information
concerning these and other factors that could cause results to differ
materially from those contained in the forward-looking statements is
contained under the caption "Risk Factors" in Eros' Prospectus dated
July 9, 2014 filed with the U.S. Securities and Exchange Commission.
Eros undertakes no obligation to revise the forward-looking statements
included herein to reflect any future events or circumstances, except as
required by law. Eros' actual results, performance or achievements could
differ materially from the results expressed in, or implied by, these
forward-looking statements.

Seasonality

The Groups' financial position and results of operations for any period
fluctuate due to film release schedules. Film release schedules take
account of holidays and festivals in India and elsewhere, competitor
film releases and sporting events.

About Eros International, Plc

Eros International Plc (NYSE: EROS) is a leading global company in the
Indian film entertainment industry that acquires, co-produces and
distributes Indian films across all available formats such as cinema,
television and digital new media. Eros International Plc was the first
Indian media company to list on the New York Stock Exchange. Eros
International has experience of over three decades in establishing a
global platform for Indian cinema. The Company has a competitive
advantage through its extensive and growing movie library comprising of
over 3,000 films, which include Hindi, Tamil, and other regional
language films for home entertainment distribution. Eros International
has built a dynamic business model by combining the release of new films
every year with the exploitation of its film library. The company also
owns the rapidly growing OTT platform Eros Now. For further information
please visit: www.erosplc.com

       

EROS INTERNATIONAL PLC

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Unaudited,
In thousands)

 
 

As at December 31,
2016

As at March 31,
2016

 

(Recasted)*

 

ASSETS
Non-current assets
Property, plant and equipment $ 10,372 $ 10,686
Goodwill 5,012 5,097
Intangible assets - trade name 14,000 14,000
Intangible assets – content 848,427 795,139
Intangible assets – others 4,790 6,127
Available-for-sale financial assets 29,917 30,147
Trade and other receivables 10,848 9,521
Deferred tax assets 247 167
Other non-current assets   2,332   3,512
Total Non-current assets   925,945 $ 874,396
 
Current assets
Inventories $ 240 $ 287
Trade and other receivables 220,603 188,361
Current tax receivable 308 238
Cash and cash equivalents 135,821 182,774
Restricted deposits   6,758   1,822
Total current assets $ 363,730 $ 373,482
Total assets $ 1,289,675 $ 1,247,878
 
LIABILITIES
Current liabilities
Trade and other payables $ 68,964 $ 65,178
Short-term borrowings

203,612

219,275
Current tax payable   6,273   6,234
Total current liabilities $

278,849

$ 290,687
 
Non-current liabilities
Long-term borrowings $

90,084

$ 92,630
Other long-term liabilities 675 536
Derivative financial instruments 14,251 22,850
Deferred tax liabilities   34,782   32,002
Total Non-Current Liabilities $

139,792

$ 148,018
Total liabilities $ 418,641 $ 438,705
 
EQUITY
Share capital $ 31,866 $ 30,793
Share premium 398,886 356,865
Reserves 435,391 423,230
Other components of equity (55,039 ) (53,310 )
JSOP reserve   (15,985 )   (17,167 )
Equity attributable to equity holders of Eros International Plc $ 795,119 $ 740,411
Non-controlling interest   75,915   68,762
Total equity $ 871,034 $ 809,173
Total liabilities and shareholders' equity $ 1,289,675 $ 1,247,878
 
*On completion of purchase price allocation, the carrying amounts of
intangible assets- others, related deferred tax liabilities and
goodwill are recasted to reflect fair value adjustments relating to
acquisition of a subsidiary.
 

EROS INTERNATIONAL PLC

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited; in thousands, except per share amounts)

   
Three Months Ended December 31, Nine Months Ended December 31,
2016   2015 2016   2015
Revenue $ 57,348 $ 60,452 $ 200,319 $ 209,286
Cost of sales   (35,029 )   (42,911 )   (131,974 )   (129,442 )
Gross profit 22,319 17,541 68,345 79,844
Administrative cost (14,119 ) (17,063 )   (47,470 )   (49,084 )
Operating profit 8,200 478 20,875 30,760
Financing costs (4,005 ) (3,046 ) (12,806 ) (10,588 )
Finance income 590   822     1,824     3,672  
Net finance costs (3,415 ) (2,224 ) (10,982 ) (6,916 )
Other gains / (losses) 10,264   2,761     13,829     1,821  
Profit before tax 15,049 1,015 23,722 25,665
Income tax (3,565 ) (3,468 )   (10,194 )   (13,336 )
Profit / (Loss) for the period $ 11,484   $ (2,453 ) $ 13,528   $ 12,329  
 
Attributable to:
Equity holders of Eros International Plc $ 8,184 $ (3,818

)

 

$ 6,484 $ 4,008
Non-controlling interest 3,300   1,365     7,044    

8,321

 

 

Earnings/(loss) per share(cents)
Basic earnings/(loss) per share 13.5 (6.6

)

 

11.0 7.0
Diluted earnings/(loss) per share 12.7 (6.6

)

 

9.7 6.1
     

EROS INTERNATIONAL PLC

 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
(Unaudited; in thousands)
 

Three Months Ended
December 31,

Nine Months Ended
December 31,

2016   2015 2016   2015
 
Profit / (Loss)for the period $ 11,484 $ (2,453 ) $ 13,528 $ 12,329
 
Other comprehensive loss:
Items that will be subsequently reclassified to profit or loss
Exchange differences on translating foreign operations (4,075 ) (2,230 ) (2,852 ) (12,857 )
Reclassification of the cash flow hedge to the statement of
operations

201

201

 

602

603
   
Total other comprehensive loss for the period $ (3,874 ) $ (2,029 ) $ (2,250 ) $ (12,254 )
Total comprehensive income/(loss) for the period net of tax $ 7,610   $

(4,482

)

$

11,278

  $ 75  
 
Attributable to:
Equity holders of Eros International Plc $ 5,054 $ (5,438 ) $ 4,755 $ (5,438 )
Non-controlling interest 2,556   956   6,523   5,513  
 

EROS INTERNATIONAL PLC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

      Nine Months Ended
December 31,
Note 2016     2015
Cash flows from operating activities:
Profit before tax $ 23,722 $ 25,665
Adjustments for:
Depreciation 590 710
Share based payment 18,645 24,504
Amortization of intangible film and content rights 105,730 97,700
Amortization of other intangibles assets 1,029 705
Other non-cash items (12,898 ) 200
Net finance costs 10,982 6,916
Gain on sale of property, plant and equipment (2 )
Gain on sale of available for sale financial asset (58 )
Changes in trade and other receivables

(38,443

)

(17,553

)

Changes in inventories 41 (153 )
Changes in trade and other payables   4,195     16,168  
Cash generated from operations 113,535 154,860
Interest paid (13,744 ) (17,857 )
Income taxes paid  

(6,464

)

 

(2,707

)

Net cash generated from operating activities $ 93,327   $ 134,296  
 
Cash flows from investing activities:
Proceeds from sale of available for sale financial assets 288
Purchases of property, plant and equipment (629 ) (871 )
Proceeds from/ (investment in) restricted deposits held with banks (4,937 ) 367
Acquisition of cash and cash equivalent in a subsidiary 263
Purchase of available for sale financial assets (230 )
Purchase of intangible film and content rights (168,585 ) (154,873 )
Purchase of other intangible assets (1,357 )
Interest received   2,309     2,053  
Net cash used in investing activities $ (171,554 ) $ (154,648 )
 
Cash flows from financing activities:
Proceeds from issue of share capital 30,452 5,414
Proceeds from issue of shares by subsidiary 19 105
Proceeds from issue out of treasury shares 938 6,295
Repayment from short-term debt with maturity less than three months
(net)

(1,685

)

(12,763

)

Proceeds from short-term debt 66,524 66,280
Repayment from short-term debt (74,809 ) (36,842 )
Proceeds from long-term borrowings 16,598 5,942
Repayment of long-term borrowings   (11,225 )   (15,850 )
Net cash generated from financing activities $ 26,812   $ 18,581  
 
Net decrease in cash and cash equivalents (51,415 ) (1,771 )
Effect of exchange rate changes on cash and cash equivalents

4,462

(443

)

Cash and cash equivalents, beginning of period   182,774     153,664  
Cash and cash equivalents, end of period $ 135,821   $ 151,450  

SUPPLEMENTAL FINANCIAL DATA

 
 

1.   TRADE AND OTHER RECEIVABLES

As at
December 31,    

    March 31,    

2016 2016
 
Trade accounts receivables $ 203,585 $ 169,283
Other receivables 25,195 18,493
Prepaid charges 449 1,071
Accrued revenues   2,222   9,035
Trade and other receivables $ 231,451 $ 197,882
 
Current trade and other receivables 220,603 188,361
Non-current trade and other receivables   10,848   9,521
$ 231,451 $ 197,882

2.   BORROWINGS

 

An analysis of long-term borrowings is shown in the table below.

     

As at

  Nominal Interest Rate Maturity   December 31,
2016
  March 31,
2016
 
Asset backed borrowings  
Vehicle Loan 10.0% - 12.0% 2017-21 $ 362 $ 260
Term Loan BPLR+1.8% - 2.75% 2016-17 1,197 6,244
Term Loan BPLR+2.75% 2017-18 666 1,579
Term Loan BPLR+2.85% 2019-20 9,341 7,932
Term Loan BPLR+2.55% - 3.4% 2020-21 8,435 12,945
Term Loan MCLR+3.45% 2021-22   14,713   -
$ 34,714 $ 28,960
 
Retail bond 6.5% 2021-22 $ 61,660 $ 71,901
Revolving facility LIBOR +1.90% - 2.90% and Mandatory Cost 2016-17 115,000 123,750
Other borrowings 10.5% 2021-22   6,183   6,933
$ 182,843 $ 202,584
 
Nominal value of borrowings $ 217,557 $ 231,544
Cumulative effect of unamortized costs (1,352 )

(2,109

)

Installments due within one year   (126,121 )   (136,805 )
Long-term borrowings — at amortized cost $ 90,084 $ 92,630

Bank prime lending rate ("BPLR") and marginal cost based lending rate
("MCLR") are the Indian equivalent to LIBOR. Asset backed borrowings are
secured by fixed and floating charges over certain Group assets.

Analysis of short-term borrowings

   
 
As at
December 31,     March 31,
Nominal interest rate (%) 2016 2016
 
Asset backed borrowings
Export credit bill discounting and overdraft BPLR+1-3.5% $ 44,414 $ 20,716
Export credit and overdraft LIBOR+3.5% 23,382 26,586
Other Short-term loan 1.75% - 2.6% 3,679 -
Term Loan MCLR+4.25%   5,297       -
$ 76,772 $ 47,302
Unsecured borrowings
Commercial paper 10.0% - 13.0% - 1,511
Other Short-term loan 1.75% - 2.6% - 32,871
Other Short-term loan 12.75% 719 786
Installments due within one year on long-term borrowings 126,121 136,805
Short-term borrowings - at amortized cost $ 203,612 $ 219,275

Fair value of the long-term borrowings as at December 31, 2016 is
$192,258 (March 31, 2016: $ 195,924). Fair values of long-term financial
liabilities except retail bonds have been determined by calculating
their present values at the reporting date, using fixed effective market
interest rates available to the Companies within the Group. As at
December 31, 2016, the fair value of retail bond amounting to $46,862
(March 31, 2016: $47,922) has been determined using quoted prices from
the London Stock Exchange (LSE). Carrying amount of short-term
borrowings approximates fair value

       

3.   ISSUED SHARE CAPITAL

Number of
Shares
GBP
(in thousands)
Authorized
A ordinary shares of 30p each at December 31, 2016 and March 31, 2016 83,333,333 25,000
 
 
    Number of Shares   USD
Allotted, called up and fully paid A Ordinary
30p Shares
    B Ordinary
30p Shares
 
As at March 31, 2015   31,982,488   25,555,220   30,622
Issue of shares on July 16, 2015 300,000 138
Issue of shares on August 18, 2015 3,500 2
Issue of shares in February 2016 57,860 26
Issue of shares in March 2016 10,900 5
Transfer of B Ordinary to A Ordinary share 594,566 (594,566)
As at March 31, 2016 32,949,314 24,960,654 30,793
Issue of shares of on April 1, 2016 1,750 0
Issue of shares of on July 29, 2016 20,813 8
Issue of shares of in August, 2016 387,613 153
Issue of shares of in September, 2016 2,107,010 825
Issue of shares of in October, 2016 98,500 36
Issue of shares of in November, 2016 117,963 45
Issue of shares of in December, 2016 14,580 6
Transfer of B Ordinary to A Ordinary share 3,247,939 (3,247,939)
As at December 31, 2016 38,945,482 21,712,715 31,866
 

On June 5, 2014, the Board of Directors had approved a grant of 525,000
‘A' ordinary share awards with a fair market value of $14.95 per share,
to certain executive directors and members of senior management. These
awards vest subject to certain share price conditions being met on or
before May 31, 2015 and the employee remaining in service until May 31,
2015. On fulfillment of share price condition, 487,500 restricted shares
were issued on December 1, 2014. All these awards have since vested and
remaining 30,000 share awards, issued on November 2, 2016.

In July, August and November 2016, the Company issued 62,439 ‘A'
ordinary shares out of IPO 2006 Plan. All share options were exercised
and issued.

On June 9, 2015, the Board of Directors approved a grant of 580,000 ‘A'
ordinary shares to certain executive directors with a fair market value
of $21.34 per share. Subject to continued employment, these awards with
Nil exercise price, vest over a period of three years. In August and
October 2016, 420,000 shares of 580,000 share awards were issued of
which 210,000 shares were issued with restriction.

In September 2016, the Company issued 2,000,310 ‘A' ordinary shares to
two of its existing institutional shareholders for an aggregate
consideration of $30 million.

In the month of August, September and October 2016, the Board of
Directors approved grant of 24,500 ‘A' ordinary share awards to certain
employees with NIL value exercise price and a fair market value of $
15.91 - $ 17.01. These awards vested on grant date and were issued
immediately on vesting.

On September 8, 2016, the Board of Directors approved a grant of 100,000
‘A' ordinary share awards to a certain employee with Nil value exercise
price and a fair market value of $16.2. These awards vested on grant
date and were issued on September 23, 2016.

On October, 2016, a permitted holder of Class B shares converted
3,247,939 Class B Shares into Class A shares. This was effected through
the cancellation of 3,247,939 Class B shares and subsequent issuance of
the equivalent amount of Class A shares

On September 4, 2015 the Company entered in to an employment exit
agreement with an employee pursuant to which the board approved a grant
of 20,000 ‘A' ordinary share awards with Nil exercise price and a fair
market value of $33.66 per share. The shares were issued on November 2,
2016.

   
4. ACQUISITION
 

On August 1, 2015, Eros' subsidiary Eros International Media Limited
("EIML") acquired 100% of the shares and voting interests in Techzone.
In accordance with the terms of the agreement between the parties, EIML
issued 900,970 equity shares to the shareholders of Techzone at an
acquisition date fair value of INR 586 ($9.16) per share. Up to March
31, 2016, pending completion of valuation of assets, including
intangible assets, the purchase price was allocated on a preliminary
basis to net assets based on initial estimates. On July 31, 2016 the
valuation has been completed and purchase price allocation has been
finalized and changes recognized with retrospective effect. The impact
of the final allocation is not material to the Group's financial
position or results of operations.

   
5. SHARE BASED COMPENSATION PLANS
 

The compensation cost recognized with respect to all outstanding plans
and by grant of shares, which are all equity settled instruments, is as
follows:

  Three months ending
December 31,
  Nine months ending
December 31,
2016   2015   2016   2015
 
IPO India Plan $ 574 $ 307 $ 1,787 $ 1,167
JSOP Plan 905 903 2,716 1,792
Option award scheme 2012 102 256 599 1,357
2014 Share Plan 308 717 1,191 1,820
2015 Share Plan 80 119 295 552
Other share option awards (573) 805 1,684 3,156
Management scheme (staff share grant)   2,723   5,121   10,373   14,660
$ 4,119 $ 8,228 $ 18,645 $ 24,504

In the meeting date June 28, 2016, the Board of Directors approved the
following grants:

620,000 ‘A' ordinary share awards to certain executive directors with a
fair value of $14.68 per share. Subject to continued employment these
awards with Nil exercise price, vest over a period of three years.

200,460 ‘A' ordinary share awards to certain employees with a fair
market value of $14.68 per share. Subject to continued employment, these
awards with Nil exercise price, vest over a period of three years.

On September 8, 2016, the Board of Directors approved, 100,000 ‘A'
ordinary share awards to an employee with a fair market value of $16.2
per share. These awards vested on grant date.

On September 22, 2016, the Board of Directors approved a grant of 18,915
‘A' ordinary share awards to certain employees with Nil value exercise
price and a fair market value of $16.2. These awards vest over a period
of three years.

In the month of August, September and October 2016, the Board of
Directors approved grant of 24,500 ‘A' ordinary share awards to certain
employees with NIL value exercise price and a fair market value of $
15.91 - $ 17.01. These awards vested on grant date and were issued
immediately on vesting.

   
6. INTANGIBLE CONTENT ASSETS
 
       
Gross
Content
Assets
Accumulated
Amortization
Content
Assets
 
As at December 31, 2016      
Film and content rights $ 1,246,344 (740,513) 505,831
Content advances 340,705 340,705
Film productions     1,891     1,891
Non-current content assets $   1,588,940   (740,513)   848,427
 
As at March 31, 2016
Film and content rights $ 1,158,737 (652,651) 506,086
Content advances 284,817 284,817
Film productions     4,236     4,236
Non-current content assets $   1,447,790   (652,651)   795,139
 
   
7. EARNINGS PER SHARE
 
    Three months ended December 31, Nine months ended December 31,
2016 2015 2016 2015
(in thousands, except number of shares and earnings per share)
Basic Diluted Basic Diluted

 

Basic

Diluted Basic Diluted
Earnings/(loss) attributable to the equity holders of the parent $ 8,184   $ 8,184   $ (3,818)   $ (3,818) $ 6,484 $ 6,484 $ 4,008   $ 4,008

Potential dilutive effect related to share based compensation
scheme in subsidiary undertaking

    (265)         (588)     (347)
Adjusted earnings/(loss) attributable to equity holders of the parent

$

8,184 $ 7,919

$

(3,818) $ (3,818) $ 6,484 $ 5,896 $ 4,008 $ 3,661
Number of shares
Weighted average number of shares 60,465,835 60,465,835 57,875,447 57,875,447

 

58,964,412

58,964,412 57,648,926 57,648,926

Potential dilutive effect related to share based compensation
scheme

  1,972,602     1,680,698     1,970,277
Adjusted weighted average number of shares

60,465,835

62,438,437 57,875,447 57,875,447 58,964,412 60,645,110 57,648,926 59,619,203
Earnings/(loss)per share
Earnings attributable to the equity holders of the parent per share
(cents)
  13.5   12.7   (6.6)   (6.6)   11.0   9.7   7.0   6.1
 

The above table does not split the earnings per share separately for the
‘A' ordinary 30p shares and the ‘B' ordinary 30p shares as there is no
variation in their entitlement to participate in undistributed earnings.

   
8. BUSINESS SEGMENTAL DATA
 

Revenues are presented based on customer location:

       
Three months ended
December 31,
 

 

Nine months ended

December 31,

2016   2015 2016   2015
 
Revenue by customer's location
India $ 24,810 $ 33,603 $

109,532

$ 127,679
Europe 1,464 6,228

7,331

13,920
North America 4,528 5,265

9,255

15,452
Rest of the world   26,546 15,356  

74,201

  52,235
Total Revenue $ 57,348 $ 60,452 $

200,319

$ 209,286
 
    Three months ended
December 31,
    Nine months ended

December 31,

2016   2015     2016   2015
 
Revenue by group's operation
India $ 19,647 $ 33,991 $ 102,248 $ 128,549
Europe 5,860 6,257

15,053

22,857
North America 569 4,088 2,461 13,983
Rest of the world   31,272 16,116   80,557   43,897
Total Revenue $ 57,348 $ 60,452 $ 200,319 $ 209,286
 
   
9. Other Gains/(Losses)
 
  Three months ended
December 31,
  Nine months ended
December 31,
2016   2015   2016   2015
 
Gains on disposal of property, plant and equipment $   $  

$

2

Gain on sale of available for sale financial assets 58
Net foreign exchange (losses)/gains 1,722 (346 ) 5,172 (204 )
Net gains/(losses) on held for trading financial liabilities   8,542   3,107   8,599   2,023  
$ 10,264 $ 2,761 $ 13,829 $ 1,821  

The net gains/( losses) on held for trading financial liabilities in the
three and nine months ended December 30, 2016 and 2015, respectively,
principally relate to derivative instruments not designated in a hedging
relationship.

   
10. NON-CASH EXPENSES
 

Significant non-cash expenses except loss on sale of assets, share based
compensation, depreciation, derivative interest and amortization were as
follows:

  Nine months ended

December 31,

2016   2015
 
Net (gains)/losses on held for trading financial liabilities $ (8,599 ) $ (2,023 )
Provisions for trade and other receivables 290 1,188
Balances written back (367 )
Impairment loss on content advances 950 490
Unrealized foreign exchange (gain)/loss (5,172 )
Others       545  
$ (12,898

)

$ (200 )
   
11. NON GAAP-FINANCIAL MEASURES
 

Adjusted EBITDA

  Three months ended December 31,  

Nine months ended December 31,

2016   2015   2016   2015
(in thousand)      
Net income $ 11,484   $ (2,453 ) $ 13,528 $ 12,329
Income tax expense 3,565 3,468 10,194 13,336
Net finance costs 3,415 2,224 10,982 6,916
Depreciation 197 288 590 710
Amortization(1) 259 241 1,029 705
Share based payments(2) 4,119 8,228 18,645 24,504
Gains on sale of available – for – sale financial assets - - (58 ) -
Net losses/(gains) on held for trading financial liabilities   (8,542 )   (3,107 )   (8,599 )  

(2,023

)

Adjusted EBITDA $ 14,497   $ 8,889   $ 46,311   $ 56,477  
 
(1) Includes only amortization of intangible assets other than
intangible content assets.
(2) Consists of compensation costs recognized with respect to all
outstanding plans and all other equity settled instruments.

View Comments and Join the Discussion!
 

Partner Center